The PROTEUS study is a randomized, cross-over, open-label, pharmacodynamic trial designed to
compare the antiplatelet effect of reduced maintenance doses of prasugrel and ticagrelor in
stable patients who recently had non-ST-elevation acute coronary syndrome (non-ST-elevation
myocardial infarction or unstable angina).